Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sharon Tetlow currently holds 37,500 shares of CELL GENESYS INC (CEGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Tetlow has been a net buyer of CEGE stock. They have purchased $17.5K and sold $0 worth of shares.
Sharon Tetlow's most recent insider trade was on Jun 25, 2024, when they sold 37,500 shares at $0.00 per share.
Sharon Tetlow serves as Executive at CELL GENESYS INC (CEGE). They have executed 8 insider transactions totaling $17.5K over their tenure at the company.
Sharon Tetlow holds the position of Executive at CELL GENESYS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Sharon Tetlow has shown a buying trading pattern, with $17.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sharon Tetlow was on Jul 31, 2008, when they sold $28.1K worth of CEGE shares. This transaction involved 9,051 shares at $3.11 per share.
Sharon Tetlow currently owns 37,500 shares of CELL GENESYS INC (CEGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sharon Tetlow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sharon Tetlow has 8 Form 4 filings on record as an insider at CELL GENESYS INC.
Set alerts for Sharon Tetlow and 40,000+ other insiders.